Sljedeći

Auto Play

Dr. Amaria on Genetically Modified TILs in Melanoma

1 Pogledi • 07/03/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Rodabe N. Amaria, MD, Department of Melanoma Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses genetically modified tumor infiltrating lymphocytes (TILs) for patients with advanced melanoma.

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play